Watch the Reel
The Eversense 365: A Revolutionary Step in Continuous Glucose Monitoring
The Eversense 365 is a groundbreaking implantable Continuous Glucose Monitoring (CGM) system designed to last for an entire year. Developed by Senseonics and distributed by Ascensia Diabetes Care, this innovative technology was FDA-approved in late 2024 and has since become widely available in the U.S. and Europe as of 2026.
The Importance of CGM for Diabetics
Continuous Glucose Monitoring (CGM) systems have revolutionized the way diabetics manage their blood sugar levels. Traditional methods often require frequent finger pricks and frequent monitoring, which can be inconvenient and painful. CGM systems provide real-time glucose readings, improving the ability to manage diabetes effectively.
What is the Eversense 365?
The Eversense 365 system comprises two primary components: the sensor and the transmitter.
The Sensor
The sensor is a tiny glass cylinder, approximately the size of a grain of rice. This fluorescent sensor is implanted just under the skin of the upper arm by a healthcare professional. The procedure is quick and typically takes around 10 minutes. Unlike traditional CGMs that use enzyme-based wires, the Eversense 365 employs light-based technology to measure glucose levels. This method allows the sensor to remain stable and accurate for up to 365 days, a significant improvement over the average lifespan of current sensors, which is only 12 days.
The Transmitter
The transmitter is a small, dark, oval device that sits on top of the skin, held in place by a daily adhesive. This smart transmitter powers the sensor and sends glucose data to a smartphone every 5 minutes. This continuous monitoring provides diabetics with real-time insights into their glucose levels, helping them make informed decisions about their health.
How Eversense 365 Compares to Traditional CGMs
Traditional CGM systems have significantly improved the quality of life for diabetics, but they are not without their drawbacks. The average lifespan of current sensors is only 12 days, requiring frequent replacements and associated costs. In contrast, the Eversense 365's 365-day lifespan eliminates the need for frequent sensor replacements, providing a more convenient and cost-effective solution.
Moreover, the light-based technology used in the Eversense 365 ensures consistent and accurate glucose readings, reducing the likelihood of false alarms and improving overall reliability. For over 500 million diabetics worldwide, this technology could potentially end the daily injections and frequent monitoring associated with traditional methods.
Practical Tips for Using the Eversense 365
While the Eversense 365 offers numerous benefits, it is essential to follow practical tips to ensure its effective use:
Proper Insertion and Maintenance
Ensure that the sensor is implanted by a trained healthcare professional to minimize the risk of complications. Regularly check the transmitter and adhesive to ensure they are functioning correctly and securely attached.
Regular Monitoring
Continuous monitoring is crucial for managing diabetes effectively. Regularly check your glucose readings and consult with your healthcare provider to adjust your treatment plan as needed.
Adhering to Hygiene Practices
Maintain good hygiene around the sensor and transmitter to prevent infections. Clean the area regularly and follow your healthcare provider's guidelines for care and maintenance.
Regular Check-ups
Schedule regular check-ups with your healthcare provider to ensure the sensor and transmitter are functioning correctly and to address any concerns or issues that may arise.
Important Takeaways
The Eversense 365 represents a significant advancement in continuous glucose monitoring. Its 365-day lifespan, accurate readings, and convenience make it a game-changer for diabetics worldwide. The system's light-based technology and ease of use improve the overall quality of life for diabetics, offering a more reliable and cost-effective solution.
Conclusion
The Eversense 365 is not just an improvement over traditional CGM systems; it is a revolutionary step forward in the management of diabetes. With its extended lifespan, accurate readings, and user-friendly design, it offers a promising future for diabetics. As technology continues to evolve, the Eversense 365 sets a new standard for continuous glucose monitoring, providing diabetics with the tools they need to manage their health more effectively.
Key points
- The Eversense 365 is an implantable Continuous Glucose Monitoring (CGM) system designed to last for one year.
- The Eversense 365 system comprises a tiny implanted sensor and a transmitter that sends glucose data to a smartphone every 5 minutes.
- Unlike traditional CGMs, the Eversense 365 uses light-based technology to measure glucose levels, remaining accurate for 365 days.
- The Eversense 365 eliminates the need for frequent sensor replacements, providing a more convenient and cost-effective solution compared to traditional CGMs.
- The Eversense 365's 365-day lifespan and accurate measurements could potentially end the daily injections and frequent monitoring associated with traditional diabetes management methods.
FAQ
The Eversense 365 differs from traditional methods by providing continuous, real-time glucose readings for an entire year without the need for frequent finger pricks. This implantable sensor offers a more convenient and less invasive approach to diabetes management, reducing the discomfort and hassle associated with traditional monitoring.
The Eversense 365 offers several benefits, including continuous, real-time glucose monitoring for up to a year, reducing the frequency of finger pricks, and providing an overview of glucose trends for better informed management of diabetes. Its implantable nature ensures the device remains in place, while the transmitter captures data.
Yes, the Eversense 365 is designed to be suitable for both Type 1 and Type 2 diabetes. It is particularly beneficial for individuals who require continuous glucose monitoring to effectively manage their blood sugar levels, regardless of the type of diabetes.
The Eversense 365 is known for its accuracy in providing real-time glucose readings. It uses a proprietary sensor to measure the glucose levels in the interstitial fluid, delivering reliable and precise readings. This accuracy is crucial for effective diabetes management, allowing users to make informed decisions about their insulin dosing and dietary choices.
The Eversense 365 is implanted under the skin during a quick, minimally invasive procedure. The device can be implanted by a healthcare professional in a clinical setting. The procedure typically takes less than 20 minutes. Removal is similarly quick and straightforward, ensuring a seamless process for users.
While the Eversense 365 is designed to be safe and effective, some users may experience minor side effects such as temporary discomfort, redness, or swelling at the implantation site. In rare cases, there may be a risk of infection or sensor failure. It is essential to follow the manufacturer's guidelines and consult a healthcare provider for any concerns or complications.
Products
Share this article
Related deep dives
Similar reads based on topic and creator.
Recent articles
Fresh deep dives from the latest Reels we unpacked.
Comments
Be the first to comment.